Hyku
Lexington, MA
Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins. The Hyku platform identifies molecules that covalently bind non-cysteine amino acids to aid in the creation of innovative medicines that can address present issues with a variety of disease targets, such as selectivity, druggability, and resistance.
hykubiosciences.comCompany Details
Founded
- 2021
Employees
- Between 20 - 50 employees
Raised
- $56,000,000
Headquarters Location
- Lexington, MA
Public
- No
Acquired
- No
CEO
Kleem Chaudhary
Founders
- Milind Deshpande
Company Collections
These are collections Hyku is a part of. Click on the collection name to view similar companies.
Hyku's Industries
Hyku Headquarters Location
1050 Waltham Street 3rd Floor, Lexington, MA 02421
Total Amount Raised: $56,000,000
Hyku Funding Rounds
Seed
$56,000,000
Seed Investors
Droia VenturesNovartis Venture FundRA Capital ManagementThe Mark Foundation for Cancer ResearchEisai InnovationKB Investment
Funding info provided by Diffbot.
Hyku Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Hyku.